The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant

By Scanlen M.   Paweska J.T.   Verschoor J.A.   van Dijk A.A.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1079-1088

Elsevier

Access to resources Recommend Favorite

Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL ( R) adjuvant

By Skeiky Y.A.W.   Coler R.N.   Brannon M.   Stromberg E.   Greeson K.   Thomas Crane R.   Campos-Neto A.   Reed S.G.  

Vaccine, Vol. 20, Iss. 27, 2002-09 ,pp. : 3292-3303

Elsevier

Access to resources Recommend Favorite

Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens

By Reddy S.K.   Sharma J.M.   Ahmad J.   Reddy D.N.   McMillen J.K.   Cook S.M.   Wild M.A.   Schwartz R.D.  

Vaccine, Vol. 14, Iss. 6, 1996-04 ,pp. : 469-477

Elsevier

Access to resources Recommend Favorite

Recombinant raccoon pox vaccine protects mice against lethal plague

By Osorio J.E.   Powell T.D.   Frank R.S.   Moss K.   Haanes E.J.   Smith S.R.   Rocke T.E.   Stinchcomb D.T.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1232-1238

Elsevier

Access to resources Recommend Favorite

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes

By Gilbert S.C.   Schneider J.   Hannan C.M.   Hu J.T.   Plebanski M.   Sinden R.   Hill A.V.S.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1039-1045

Elsevier

Access to resources Recommend Favorite